Home
DRUG
Main Task
Main Task
Pharmaceutical safety control
- Development of policies and establishment of comprehensive plans on the pharmaceutical safety control
- E stablishment and revision of the laws and notifications on drugs
- Provision of information on the proper use of pharmaceuticals
- Post-marketing safety control
- Re-evaluation of the safety and efficacy of human placenta based pharmaceuticals
- Introduction of Plasma Master File (PMF) system for plasma derivatives reinforcement of a management standard for imported blood plasma
- E stablishment of guidelines on an excellent management standard for human tissues (GTP) and management of tissue bank
Pharmaceutical quality control
- E stablishment of planning on management standards for Good Manufacturing Practices (GMP)
- GMP inspection and evaluation for domestic and imported drugs
- Introduction of GMP system for herbal medicines
Safety control on Narcotics
- Review of narcotics related acts and systems
- E stablishment/adjustment of basic plan for narcotics control, and management of statistics
- Approval of the manufacturing, import and export of narcotics
Pharmaceutical approval and review
- Pharmaceutical manufacturing and import approval
- Reviewing and approval of herbal medicines and Korean traditional medicines
- Operation of management system for pharmaceutical approval and application
- E stablishment and operation of pharmaceutical standards such as the Korean Pharmacopoeia, etc.
- Reviewing of the quality, safety, and efficacy of pharmaceuticals
- Reviewing of protocols
- Reviewing of the bioequivalence test protocols, result report, re-evaluation, etc.
- Approval of shipping bio pharmaceuticals based on the national verification system
Establishment of basis for nurture and support
- Supporting policies for new bio pharmaceuticals based on selection of growth engine industry
- E stablishment of evaluation system for safety and efficacy of high tech fusion technology pharmaceuticals
- Simplification of licensing/approval of bio pharmaceutical area
- E stablishment of the approval and review standards for biosimilar